Larson Financial Group LLC Coherus Bio Sciences, Inc. Transaction History
Larson Financial Group LLC
- $1.75 Billion
- Q3 2024
A detailed history of Larson Financial Group LLC transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Larson Financial Group LLC holds 147 shares of CHRS stock, worth $173. This represents 0.0% of its overall portfolio holdings.
Number of Shares
147
Previous 71,490
99.79%
Holding current value
$173
Previous $123,000
100.0%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding CHRS
# of Institutions
132Shares Held
76.9MCall Options Held
40.7KPut Options Held
50.1K-
Black Rock Inc. New York, NY11.8MShares$13.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$13.3 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.4MShares$12.3 Million0.3% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY3.04MShares$3.58 Million0.18% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.86MShares$3.37 Million0.0% of portfolio
About Coherus BioSciences, Inc.
- Ticker CHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,724,600
- Market Cap $91.7M
- Description
- Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...